Brain Cancer Diagnostics Market Size is valued at USD 1.46 Billion in 2022 and is predicted to reach USD 2.45 Billion by the year 2031 at a 6.19% CAGR during the forecast period for 2023-2031.
Brain cancer diagnostics involve the identification and characterization of brain tumours using a variety of medical tools and procedures. This encompasses many diagnostic procedures such as imaging investigations, biopsies, blood tests, genetic testing, and neurological evaluations. These tests are conducted to figure out the specific type, location, and characteristics of the brain cancer. The objective is to deliver a precise diagnostic that assists healthcare practitioners in formulating a suitable and tailored treatment regimen for those afflicted with brain cancer.
Brain cancer, characterized by the abnormal proliferation of cells in the brain leading to the new formation of tumours, is a neurological disorder involving the emergence of malignant cells in brain tissue. The expansive nature of the brain cancer market is witnessing increased attention due to a growing population affected by the ailment, drawing in additional stakeholders to engage in diagnostic advancements. Moreover, detecting brain cancer in its early stages poses a challenge, but recent developments in diagnostic product lines offer promise in addressing this concern. In Western countries, the expense of brain tumor surgery is notably high, with costs varying based on the specific procedure, location, and severity of the tumor. Consequently, the elevated costs associated with brain cancer diagnosis and treatment may pose a constraint on market growth.
The Brain Cancer Diagnostics market is segmented based on diagnostic technique, brain type, and End users. Based on diagnostic techniques, the market is segmented into imaging techniques, biopsy, molecular diagnostics, and others. The market is segmented by application into gliomas, meningiomas, pituitary tumours, and others. The end users segment is segmented into hospitals, diagnostic techniques, and cancer hospitals.
The molecular diagnostic category will hold a major share in the global brain cancer diagnostics market 2022. his upswing is primarily attributed to advancements in molecular technologies that enable more precise and personalized assessments of brain cancer. Molecular diagnostics are pivotal in identifying specific genetic and molecular alterations associated with brain tumors, offering valuable insights into their characteristics and behavior. As research and development efforts continue to unveil novel biomarkers and genetic signatures linked to different types of brain cancer, the molecular diagnostic segment is becoming increasingly integral.
The ability of molecular diagnostics to provide detailed information about the genetic makeup of tumours allows for more accurate diagnosis, prognosis, and treatment selection. This precision contributes to improved patient outcomes and underscores the rising importance of the molecular diagnostic segment in shaping the landscape of brain cancer diagnostics.
The gliomas segment is projected to grow rapidly in the global brain cancer diagnostics market. The increasing recognition of gliomas' distinct characteristics and complexities has fueled a surge in research and diagnostic developments dedicated to this segment. Advancements in imaging technologies and molecular diagnostics have played a crucial role in enhancing the identification and classification of gliomas. The rising emphasis on precision medicine has led to a more nuanced understanding of gliomas' genetic and molecular profiles, enabling tailored diagnostic approaches. As the understanding of gliomas continues to evolve, the diagnostic segment dedicated to these tumours is witnessing growth. This reflects the healthcare industry's commitment to addressing the unique challenges gliomas pose in the broader landscape of Brain Cancer Diagnostics.
The North America Brain Cancer Diagnostics market is expected to register the highest market share. The Brain Cancer Diagnostics Market in North America exhibits a robust and dynamic landscape characterized by significant advancements in technology, extensive research and development activities, and a strong presence of key industry players. The United States, in particular, holds a leading position within this region, contributing substantially to the overall market growth. Technological innovations in brain cancer diagnostics, such as advanced imaging modalities and molecular diagnostic tools, have played a notable role in enhancing the accuracy and efficiency of diagnoses.
The region benefits from a high level of investment in healthcare infrastructure and research, fostering an environment conducive to developing and adopting cutting-edge diagnostic technologies. In addition, Europe is estimated to grow rapidly in the global Brain Cancer Diagnostics market. Collaborative initiatives between European nations and international partners contribute to knowledge exchange in brain cancer diagnostics. These collaborations facilitate the development of standardized diagnostic protocols and the sharing of research findings, ultimately contributing to advancements in brain cancer diagnosis. Moreover, awareness campaigns and educational programs across Europe play a crucial role in advertising early detection and diagnosis of brain cancer.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 1.46 Billion |
|
Revenue Forecast In 2031 |
USD 2.45 Billion |
|
Growth Rate CAGR |
CAGR of 6.19 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Diagnostic Technique, By Brain Cancer Type, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd., Neusoft Medical Systems, Abbott Laboratories, Roche Holding AG, Bio Rad Laboratories Inc., Illumina, Inc., Bristol-Myers Squibb, Toshiba Medical Systems Corporation, Agilent Technologies Inc., Hologic, Inc., Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Brain Cancer Diagnostics Market Snapshot
Chapter 4. Global Brain Cancer Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Diagnostic Technique Estimates & Trend Analysis
5.1. By Diagnostic Technique, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Diagnostic Technique:
5.2.1. Imaging Techniques
5.2.1.1. Magnetic Resonance Imaging (MRI),
5.2.1.2. Computed Tomography (CT) Scan
5.2.1.3. PET Scan or PET-CT Scan
5.2.1.4. Single-photon Emission Computed Tomography (SPECT) Scan
5.2.2. Tissue Sampling/Biopsy
5.2.3. Molecular Diagnostics
5.2.4. Others
Chapter 6. Market Segmentation 2: By Brain Cancer Type Estimates & Trend Analysis
6.1. By Brain Cancer Type & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Brain Cancer Type:
6.2.1. Gliomas
6.2.2. Meningiomas
6.2.3. Pituitary tumors
6.2.4. Others
Chapter 7. Market Segmentation 3: By End-user Estimates & Trend Analysis
7.1. By End-user & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By End-user:
7.2.1. Hospitals
7.2.2. Diagnostic Laboratories
7.2.3. Cancer Hospitals/Centers
Chapter 8. Brain Cancer Diagnostics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Brain Cancer Diagnostics Market revenue (US$ Million) estimates and forecasts By Diagnostic Technique, 2023-2031
8.1.2. North America Brain Cancer Diagnostics Market revenue (US$ Million) estimates and forecasts By Brain Cancer Type, 2023-2031
8.1.3. North America Brain Cancer Diagnostics Market revenue (US$ Million) estimates and forecasts By End-user, 2023-2031
8.1.4. North America Brain Cancer Diagnostics Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
8.2. Europe
8.2.1. Europe Brain Cancer Diagnostics Market revenue (US$ Million) By Diagnostic Technique, 2023-2031
8.2.2. Europe Brain Cancer Diagnostics Market revenue (US$ Million) By Brain Cancer Type, 2023-2031
8.2.3. Europe Brain Cancer Diagnostics Market revenue (US$ Million) By End-user, 2023-2031
8.2.4. Europe Brain Cancer Diagnostics Market revenue (US$ Million) by country, 2023-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Brain Cancer Diagnostics Market revenue (US$ Million) By Diagnostic Technique, 2023-2031
8.3.2. Asia Pacific Brain Cancer Diagnostics Market revenue (US$ Million) By Brain Cancer Type, 2023-2031
8.3.3. Asia Pacific Brain Cancer Diagnostics Market revenue (US$ Million) By End-user, 2023-2031
8.3.4. Asia Pacific Brain Cancer Diagnostics Market revenue (US$ Million) by country, 2023-2031
8.4. Latin America
8.4.1. Latin America Brain Cancer Diagnostics Market revenue (US$ Million) By Diagnostic Technique, (US$ Million) 2023-2031
8.4.2. Latin America Brain Cancer Diagnostics Market revenue (US$ Million) By Brain Cancer Type, (US$ Million) 2023-2031
8.4.3. Latin America Brain Cancer Diagnostics Market revenue (US$ Million) By End-user, (US$ Million) 2023-2031
8.4.4. Latin America Brain Cancer Diagnostics Market revenue (US$ Million) by country, 2023-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Brain Cancer Diagnostics Market revenue (US$ Million) By Diagnostic Technique, (US$ Million) 2023-2031
8.5.2. Middle East & Africa Brain Cancer Diagnostics Market revenue (US$ Million) By Brain Cancer Type, (US$ Million) 2023-2031
8.5.3. Middle East & Africa Brain Cancer Diagnostics Market revenue (US$ Million) By End-user, (US$ Million) 2023-2031
8.5.4. Middle East & Africa Brain Cancer Diagnostics Market revenue (US$ Million) by country, 2023-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. GE Healthcare
9.2.2. Thermo Fisher Scientific Inc.
9.2.3. Siemens Healthineers AG
9.2.4. GE Healthcare
9.2.5. MDxHealth
9.2.6. NantOmics
9.2.7. Biocept, Inc.
9.2.8. Koninklijke Philips N.V.
9.2.9. Canon Medical Systems
9.2.10. Hitachi, Ltd.
9.2.11. Neusoft Medical Systems
9.2.12. Abbott Laboratories
9.2.13. Roche Holding AG
9.2.14. Bio Rad Laboratories Inc.
9.2.15. Illumina, Inc.
9.2.16. Bristol-Myers Squibb
9.2.17. Toshiba Medical Systems Corporation
9.2.18. Agilent Technologies Inc.
9.2.19. Hologic, Inc.
9.2.20. Others
Brain Cancer Diagnostics Market By Diagnostic Technique-
Brain Cancer Diagnostics Market By Brain Cancer Type-
Brain Cancer Diagnostics Market By End-Users
Brain Cancer Diagnostics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
